The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N06 | Psychoanaleptics | |
| 3 | N06B | Psychostimulants, agents used for ADHD and nootropics | |
| 4 | N06BC | Xanthine derivatives |
| Code | Title | |
|---|---|---|
| N06BC01 | Caffeine | |
| N06BC02 | Propentofylline |
| Active Ingredient | Description | |
|---|---|---|
| Caffeine |
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| Caffeine Citrate 10mg/ml Inj. Sol. | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| GENCEBOK Solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| PEYONA Solution | European Medicines Agency (EU) | MPI, EU: SmPC |